Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 January 2025 | Story Lacea Loader | Photo Supplied
Jurie Blignaut
Jurie Blignaut, top achiever in the 2024 matric exams for quintile four schools in SA and finalist of the UFS 2024 Matriculant of the Year competition.

The University of the Free State (UFS) is proud to announce that the top achiever in the 2024 matric exams for quintile four schools in the country, Jurie Blignaut, will be studying towards an MBChB at the UFS from 2025.

Blignaut, a pupil of the Rustenburg High School, was one of the 14 finalists in the 2024 UFS Matriculant of the Year competition.

“Congratulations to Jurie on this wonderful achievement. We look forward to welcoming him and our cohort of 2025 first-year students to our campuses,” says Prof Anthea Rhoda, acting Vice-Chancellor and Principal of the UFS. 

Boasting 11 distinctions and an average of 96,5%, Blignaut is not only an exceptional academic achiever but also participates in several cultural activities. He was the winner of the Kovsie Alumni Trust’s special award for personal cultural achievement in the final round of the competition. This head boy of his school is an excellent public speaker and musician. 

Blignaut’s highest achievement in public speaking was his national second place in last year’s ATKV public speaking competition in the section for Afrikaans home language. He plays the cello and has performed solo with the Pretoria Symphony Orchestra, was part of the school choir and band, and participated in the Stellenbosch International Chamber Music Festival. 

“On behalf of the university management, I would also like to congratulate Dr Mantlhake Maboya, MEC for Education in the Free State, and her executive team on the Free State being the top-achieving province in South Africa,” says Prof Rhoda. 

Other finalists in the 2024 UFS Matriculant of the Year competition who excelled during the matric exams include Susan Bender from Voortrekker High School – top achiever in the Free State province – and Chris Goosen from Grey College Secondary School, who is also one of the top achievers in the Free State. 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept